<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhu X</submitter><funding>Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China</funding><funding>Science and Technology Commission of Shanghai Municipality, China</funding><funding>Shanghai Municipal Commission of Health and Family Planning, China</funding><pagination>497-504</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6422475</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(4)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Angiogenesis is one of the key processes in the development of malignant tumors. The vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2) signaling pathway regulates branching angiogenesis in cancer. In this study, we analyzed the associations of VEGF/VEGFR-2 proteins and VEGFR-2 genetic variations with the prognosis of gastric cancer (GC).&lt;h4>Method&lt;/h4>We collected the clinical information of patients with GC and extracted genomic DNA from paraffin-embedded tissues. Immunohistochemical methods were used to detect the expression of VEGF and VEGFR-2 in GC tissues. Four single nucleotide polymorphisms of VEGFR-2 were detected by the TaqMan assay. The Kaplan-Meier method and Cox regression model were applied to analyze the associations between clinicopath</pubmed_abstract><journal>Cancer biology &amp; therapy</journal><pubmed_title>The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer.</pubmed_title><pmcid>PMC6422475</pmcid><funding_grant_id>Grant No.15ZR1427700</funding_grant_id><funding_grant_id>Grant No.15LC05 and No. 13YJ22</funding_grant_id><funding_grant_id>Grant No. 201540271</funding_grant_id><pubmed_authors>Xue W</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Zheng L</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Zhu ML</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer.</name><description>&lt;h4>Objective&lt;/h4>Angiogenesis is one of the key processes in the development of malignant tumors. The vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2) signaling pathway regulates branching angiogenesis in cancer. In this study, we analyzed the associations of VEGF/VEGFR-2 proteins and VEGFR-2 genetic variations with the prognosis of gastric cancer (GC).&lt;h4>Method&lt;/h4>We collected the clinical information of patients with GC and extracted genomic DNA from paraffin-embedded tissues. Immunohistochemical methods were used to detect the expression of VEGF and VEGFR-2 in GC tissues. Four single nucleotide polymorphisms of VEGFR-2 were detected by the TaqMan assay. The Kaplan-Meier method and Cox regression model were applied to analyze the associations between clinicopath</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2026-04-08T03:16:55.844Z</modification><creation>2019-11-07T08:03:20Z</creation></dates><accession>S-EPMC6422475</accession><cross_references><pubmed>30380970</pubmed><doi>10.1080/15384047.2018.1537575</doi></cross_references></HashMap>